Abstract 2394: A novel 2+2 IgG-like bispecific antibody-drug conjugate targeting EBV GP220/350 and EGFR for selective treatment of nasopharyngeal carcinoma.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Saihong Yu, Yunxia Zheng, Junxiang Jia, Xiangfei Kong, Juan Wang, Yi Luo, Hangbo Ye, Xueqing Ma, Qingliang Yang, Robert Y. Zhao
Institution: Hangzhou DAC Biotech (China)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148712608